ALERT!!
NEW FEATURE AVAILABLE – CHECK IT OUT: There is a new SHOW MARKUP button that allows you to view the manuals in a whole new way. Show or hide revisions in a section; the choice is yours. Go to any page within the manuals and use the new button now!
The Managed Care Support (MCS) Manuals (T-3) for contracts prior to 07/21/2016 are now superseded and can be found in the "Superseded" portion (indicated by a red banner) of each T-17 manuals' web page.
Medicine
Chapter 7
Section 25.1
Dermoscopy
Issue Date: June 19, 2008
Copyright: CPT only © 2006 American Medical
Association (or such other date of publication of CPT).
All Rights Reserved.
Revision:
1.0 CPT PROCEDURE CODES
96904
2.0 DESCRIPTION
Early phases of malignant melanoma
can be difficult to detect. Surgery (i.e., biopsy) to remove the
melanoma is the standard treatment for this disease. However, a
number of surveillance technologies have been developed in an attempt
to improve accuracy in diagnosing malignancies in pigmented skin
lesions without using a biopsy or excision (removal) of the lesion
itself.
Dermoscopy
(also known as Digital Epiluminescence Microscopy (DELM), dermatoscopy, melanomography,
in vivo cutaneous surface microscopy, mole mapping, and magnified
oil immersion diascopy) is one of technologies designed for detecting
and monitoring dysplastic and atypical nevi for early detection
of malignant cutaneous melanomas. The dermoscope allows 10x or higher magnification
by using high intensity light. Oil placed between the skin and the
lens makes the skin more transparent and enables visualization of
skin structures to the bottom of the outermost layer of the skin.
This technology offers the physician the ability to have a baseline
image to refer to so he or she can examine each suspicious lesion,
and then compare them year after year, by re-imaging.
3.0 POLICY
The Dermoscopy technique for
diagnosing and monitoring dysplastic and atypical nevi for early
detection of malignant cutaneous melanoma in patients with suspicious
pigmented skin lesions is not covered because it is considered unproven.
- END -